Want to see RLMD full AI Analyst Report?
Relmada Therapeutics (RLMD) Ownership Overview
2.82% Insiders
3.68% Mutual Funds
49.86% Other Institutional Investors
11.34% ETFs
32.30% Public Companies and
Individual Investors
The ownership structure of Relmada Therapeutics (RLMD) stock is a mix of institutional, retail, and individual investors. Approximately 64.88% of the company’s stock is owned by Institutional Investors, 2.82% is owned by Insiders, and 32.30% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 16, 2025 | xxxxxxxxxxxxx | $48060 | |
Dec 16, 2025 | xxxxxxxxxxxxx | $113300 | |
Nov 06, 2025 | xxxxxxxxxxxxx | $1100000 | |
Nov 06, 2025 | xxxxxxxxxxxxx | $299200 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $16705 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $2272673 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,536,671 | Institution | 5.19% | 25,025,753 | |
| 3,803,225 | Institution | 3.57% | 17,190,577 | |
| 3,005,281 | Institution | 2.82% | 13,583,870 | |
| 2,947,369 | Institution | 2.76% | 13,322,108 | |
| 2,132,053 | Institution | 2.00% | 9,636,880 | |
| 1,300,000 | Insider | 1.22% | 5,876,000 | |
| 1,192,719 | Institution | 1.12% | 5,391,090 | |
| 800,000 | Insider | 0.75% | 3,616,000 | |
| 637,428 | Institution | 0.60% | 2,881,175 | |
| 525,481 | Institution | 0.49% | 2,375,174 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,005,281 | Institution | 2.82% | 13,583,870 | |
| 637,428 | Institution | 0.60% | 2,881,175 | |
| 91,078 | Institution | 0.09% | 411,673 | |
| 53,081 | Institution | 0.05% | 239,926 | |
| 52,182 | Institution | 0.05% | 235,863 | |
| 38,589 | Institution | 0.04% | 174,422 | |
| 32,256 | Institution | 0.03% | 145,797 | |
| 10,026 | Institution | <0.01% | 45,318 | |
| 2,078 | Institution | <0.01% | 9,393 | |
| 1,236 | Institution | <0.01% | 5,587 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,169,804 | Institution | 2.97% | 16,831,659 | |
| 2,418,327 | Institution | 2.27% | 10,930,838 | |
| 1,206,656 | Institution | 1.13% | 6,407,343 | |
| 872,255 | Institution | 0.82% | 3,942,593 | |
| 830,393 | Institution | 0.78% | 3,778,288 | |
| 545,481 | Institution | 0.51% | 2,465,574 | |
| 530,284 | Institution | 0.50% | 2,815,808 | |
| 324,890 | Institution | 0.30% | 1,468,503 | |
| 274,174 | Institution | 0.26% | 1,247,492 | |
| 263,037 | Institution | 0.25% | 1,196,818 |
FAQ
Who Owns Relmada Therapeutics (RLMD)?
According to the latest TipRanks data, approximately 49.86% of the company's stock is held by institutional investors, 2.82% is held by insiders, and 32.30% is held by retail investors.
What percentage of Relmada Therapeutics (RLMD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 49.86% of Relmada Therapeutics (RLMD) stock is held by institutional investors.
What percentage of Relmada Therapeutics (RLMD) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.30% of Relmada Therapeutics (RLMD) stock is held by retail investors.
Who owns the most shares of Relmada Therapeutics (RLMD)?
Vanguard owns the most shares of Relmada Therapeutics (RLMD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.